Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-Week repeated oral administration in rats
- 25 September 2003
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 24 (9) , 409-418
- https://doi.org/10.1002/bdd.377
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2002
- Subacute toxicities and toxicokinetics of a new erectogenic, DA-8159, after single and 4-week repeated oral administration in dogsBiopharmaceutics & Drug Disposition, 2001
- Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA‐8159, using an equilibrium dialysis techniqueBiopharmaceutics & Drug Disposition, 2000
- Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunctionClinical Therapeutics, 1998
- Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curveJournal of Pharmacokinetics and Biopharmaceutics, 1978